Filing Details

Accession Number:
0001493152-18-010762
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-07-31 21:38:54
Reporting Period:
2018-07-26
Accepted Time:
2018-07-31 21:38:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1642380 Oncocyte Corp OCX In Vitro & In Vivo Diagnostic Substances (2835) 271041563
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689836 K. Lyndal Hesterberg 1010 Atlantic Ave,
Suite 102
Alameda CA 94501
Sr Vp, Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2018-07-26 874 $0.00 874 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common stock purchase warrants Acquisiton 2018-07-26 874 $0.00 874 $3.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
874 2019-02-01 2024-02-01 No 4 P Direct
Footnotes
  1. The shares of common stock and the common stock purchase warrants reported in this Form were purchased in "units," with each unit consisting of one share of common stock and one common stock purchase warrant. The purchase price per unit was $2.86.